Table 2.

Characteristics of endometrial cancer concurrent with endometrial hyperplasia.

	n = 43
Histology subtype
Endometrioid	39 (90.7%)
Endometrioid + mucinous	3 (7.0%)
Endometrioid + serous	1 (2.3%)
Grade
1	37 (86.0%)
2	3 (7.0%)
3	3 (7.0%)
Stage
IA	36 (83.7%)
II	4 (9.3%)
IIIA	1 (2.3%)
IIIC1	2 (4.7%)
Myometrial tumor invasion (%)	8 (0–100)
None	13 (30.2%)
Inner third	24 (55.8%)
Middle third	3 (7.0%)
Outer third	3 (7.0%)
LVSI
No	40 (93.0%)
Yes	3 (7.0%)
Lymphadenectomy
Pelvic	5 (11.6%)
Para-aortic	2 (4.7%)
Any	6 (14.0%)
Survival outcome
Follow-up time (months)	48.6 (1.8–141.9)
Recurrence	0
Die of cancer	0

Number (%) or median (range) is shown. Abbreviations: LVSI, lymphovascular space invasion.